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ABSTRACT 
 
The Roles of Primary Cilia in Cardiovascular Diseases and cancer   
by Maha Hassan Jamal 
Primary cilia are sensory organelles present in most mammalian cell types and regulate cell cycle 
and signaling pathways. Biochemical and molecular dysfunctions of primary cilia are associated 
with a wide range of diseases, including cancer, ciliopathies polycystic kidney disease (PKD, liver 
disorders, mental retardation, and obesity to cardiovascular diseases. Dysfunction in endothelial 
cilia contributes to aberrant fluid-sensing and results in vascular disorders, such as hypertension, 
aneurysm, and atherosclerosis. In this dissertation, the most recent outcomes on the roles of 
endothelial primary cilia within vascular biology have been summarized. Moreover, we evaluate 
the correlation between cilia formation or length and cell cycle or division using PKD and cancer 
epithelia. The results show that these cells were associated with abnormal ploidy and were highly 
proliferative compared with normal kidney epithelia (NK). Importantly, the cancer epithelial cells 
show a reduction in the presence and/or length of primary cilia. Restoration of the expression and 
length of primary cilia in these cells using rapamycin were inversely correlated with cell 
proliferation.  Our data suggest that primary cilia may serve as a novel target in cardiovascular 
disorder and cancer. 
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Chapter 1: Primary Cilia Preview  
1.1. Introduction: 
Cilia are sensory organelles expressed on the surface of most of the non-haematological cells [1]. 
The structure of the cilium is divided into 3 parts: the basal body (BB), the axoneme, and the 
transition zone (TZ) [2,3]. Cilia are classified into motile and non-motile (primary) cilia. Motile 
cilia have (9+2) microtubule arrangement while primary or non-motile cilia lack the central pair 
of microtubules, with a (9+0) microtubule arrangement [4]. Primary cilia act as antennae that 
transmit extracellular signals into intracellular biochemical responses that regulate proliferation, 
differentiation, and migration [5,6]. 
1.2. Primary Cilia Structure: 
The cilium is a membrane bound structure that is composed of microtubule bundles (ciliary 
axoneme) originating from the basal body. The axonemal structure contains microtubules that are 
made of a and b tubulins that are post translationally acetylated to support the cilia structure [7].  
Intra-flagellar transport (IFT) is an essential protein complex required for growth and 
maintenance of both motile and non-motile cilia. Kinesin 2 motor proteins transport the cargo 
proteins in the anterograde direction to the tip of the cilium while cytoplasmic dynein 2 motor 
proteins transport cargo proteins in the retrograde direction towards the basal body [8].  
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1.3.  Ciliogenesis and Cell Cycle Regulation: 
Ciliogenesis or the timing of cilium formation is controlled by the phases of cell cycle [9]. 
Formation of primary cilia typically begins at the G1/G0 phase of the cell cycle when the mother 
centriole in the centrosome acts as a basal body to start cilia formation [10]. As cells re-enter the 
cell cycle, the cilium and the basal body disassembled releasing the centrioles to work as the 
organizing center for the mitotic spindles during cell division [11]. As the cells enter the quiescence 
phase (G0), the mother centriole forms the basal body and the primary cilium is re-assembled [12]. 
So, cilium acts as a brake for cell cycle progression by holding the basal body and can stop 
abnormal cell growth by restricting cell cycle [2]. 
1.4. Primary Cilia as  Mechanosensors:  
Primary cilia are physical–chemical sensors that respond to many stimuli, such as flow stress [4]. 
Physical stimulation, such as fluid flow, causes primary cilia deflection to increase intracellular 
calcium, decrease intracellular cAMP, and stimulate downstream mechanotransduction signaling 
cascades that regulate cell proliferation [2]. Defects in proteins, receptors or ion channels, that 
localize to the primary cilium, basal body, and/ or centrosomes, such as the case in polycystic 
kidney disease, result in defective flow sensing leading to uncontrolled cell proliferation and cyst 
formation [13–15].  
1.5. Signaling Pathways: 
Cilia have been implicated in signaling pathways including the Hedgehog (Hh), Wnt and Platelets- 
Derived Growth Factor (PDGF) pathways [1,14].  
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Hedghog (Hh) Signaling Pathway: 
Hedgehog (Hh) is one of the essential signaling pathways that is involved in development as well 
as in homeostasis and regeneration. In the absence of Hh ligand, the Patched (PTCH1) receptor 
binds and inhibits the activity of the seven transmembrane-domain protein Smoothened (SMO), a 
central activator of the pathway. On the other hand, binding of Hh ligand to Ptch1 relieves its 
inhibition of Smo, thus smo is allowed to stimulate downstream Gli activators and inhibit the 
formation of Gli repressors [16]. Hedghog deregulation was observed in variety of cancer types [ 
17] such as basal cell carcinoma [18], breast cancer [19], liver cancer [20], and colon cancer [21]. 
Previous studies have shown that the primary cilium has a crucial role in regulating Hh signaling 
[22]. Wong S. et al showed that primary cilia can either induce or suppress tumor formation 
depending on the nature of the oncogenic initiating factor [23]. 
Wnt Signaling Pathway: 
Wnt signaling pathway regulates the balance between cellular differentiation, polarity controls and 
proliferation to regulate tissue homeostasis. In the absence of canonical Wnt-signaling, the 
“destruction complex”, which is composed of Axin, adenomatous polyposis coli (APC), and 
glycogen synthase kinase 3-b (GSK3-β) targets β-catenin to the proteasome for degradation, 
inhibiting translocation of β-catenin into the nucleus to activate gene expression. Binding of Wnt 
ligands to a membrane-bound Frizzled (Fzd) receptor, which then binds lipoprotein receptor 
related protein 5 and 6 (LRP5/6), allows the recruitment of Axin with LRP5/6; thus the 
Axin/APC/GSK3-β “destruction complex” can no longer degrade β-catenin. Then β-catenin can 
freely enter the nucleus, with the help of AHI1, to interact with transcription factors to activate 
Wnt gene expression. The Wnt signal is transduced through Disheveled (Dvl), which is recruited 
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to the membrane and binds Axin upon stimulation. The presence of primary cilium controls the 
level of expression of Wnt target genes by (1) controlled degradation of Dvl by the proteins: 
inversin (INVS) and nephrolithiasis (NPHP) that are localized in the primary cilium and (2) 
sequestering AHI1 at the cilium so it becomes unable to help β-catenin to translocate into the 
nucleus [2,9]. 
In this thesis, the first part reviews the crucial role of primary cilia in cardiovascular disease while 
the second part assesses the relationship among Wnt signaling pathway, cell proliferation and 
primary cilia. 
Hypothesis:  
Cilia length is associated with cancer progression, and specific pathways in cilia associated with 
cancer cell cycle can be modulated. 
Aims: 
1. To karyotype and validate the cancer cells. 
2. To characterize the expression of the primary cilia and assess the cell proliferation and 
Wnt signaling pathway in cancer cells. 
3. To restore primary cilia expression in cancer cells using Sirolimus (Rapamycin) and then: 
a) Characterize the expression of the primary cilia. 
b) Evaluate the association between re-expression of primary cilia and cancer cell 
proliferation.  
c) Investigate the correlation between primary cilia and Wnt signaling pathways after 
restoring primary cilia expression in cancer cells.
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Chapter 2: The Roles of Primary Cilia in 
Cardiovascular Diseases 
Pala R, Jamal M, Alshammari Q, Nauli SM. The Roles of Primary Cilia in Cardiovascular 
Diseases. Cells. 2018;7(12):233. 
 
2.1. Abstract 
Primary cilia are microtubule-based organelles found in most mammalian cell types. Cilia act as 
sensory organelles that transmit extracellular clues into intracellular signals for molecular and 
cellular responses. Biochemical and molecular defects in primary cilia are associated with a wide 
range of diseases, termed ciliopathies, with phenotypes ranging from polycystic kidney disease, 
liver disorders, mental retardation, and obesity to cardiovascular diseases. Primary cilia in vascular 
endothelia protrude into the lumen of blood vessels and function as molecular switches for calcium 
(Ca2+) and nitric oxide (NO) signaling. As mechanosensory organelles, endothelial cilia are 
involved in blood flow sensing. Dysfunction in endothelial cilia contributes to aberrant fluid-
sensing and thus results in vascular disorders, including hypertension, aneurysm, and 
atherosclerosis. This review focuses on the most recent findings on the roles of endothelial primary 
cilia within vascular biology and alludes to the possibility of primary cilium as a therapeutic target 
for cardiovascular disorders.  
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2.2. Introduction 
Cilia have been studied for their motile functions of lung epithelium, sperm cells, as well as in 
other organisms (such as algae) [1]. These motile cilia, in most cases, have 9 + 2 microtubule 
structural arrangement. Researchers have also gained interest in studying non-motile cilia [2]. 
Non-motile cilia also known as primary cilia have a 9 + 0 microtubule structural arrangement. 
Defects in primary cilia could cause various life-threatening diseases in humans, such as neural 
tube defects, which result in numerous abnormalities of the brain and spinal cord in patients 
diagnosed with Meckel syndrome, for example [3]. Several studies have shown that primary cilia 
are recognized as mechanical and chemical sensory organelles which serve as antennae to transmit 
extracellular to intracellular signaling mechanisms. Because primary cilia act as sensory organelles 
by which cells sense and transduce extracellular signals [4], any defects in primary cilia function 
could potentially cause several diseases which are collectively known as ‘ciliopathies’ (Table 1). 
The list of human ciliopathies has increased in recent years [5,6]. Mutations in approximately 50 
genes have revealed to alter ciliary assembly or function, and as many as 1000 different ciliary 
proteins are still with undetermined functions and required further investigation. Hence, abnormal 
ciliary proteins can be associated with a single organ dysfunction to systemic multiple organ 
complications depending on the type of cells affected [7].  
Table 0.1: Ciliary Function and Disease Relevance. 
Function Disease Relevance Reference 
Nodal flow sensing Situs inversus; Situs ambiguous; Situs isomerism [14,15] 
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Function Disease Relevance Reference 
Mechano-sensing Kidney, Liver, and Pancreas Diseases [16,17,18] 
Shear stress sensing Hypertension; Atherosclerosis; Aneurysm formation [10,11,12,13] 
Osmolarity sensing Respiratory diseases; Infertility [19,20] 
Gravitational sensing Osteoporosis; Chondroporosis [21,22,23] 
Olfaction sensing Anosmia; Hyposmia [24,25] 
Light sensing Retinitis pigmentosa; Blindness [26,27,28] 
Chemo-sensing Nephrocystin; Diabetes; Obesity [29,30,31] 
Neurotransmitter sensing Impaired brain plasticity [32] 
Developmental regulatory 
sensing Developmental defects; Cancer [33,34,35] 
Pressure sensing Bone maintenance, development [22,36,37] 
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Cilia dysfunction has been implicated in polycystic kidney disease (PKD), obesity, 
nephronophthisis, mental retardation, Bardet-Biedl syndrome, oral facial syndrome, vascular 
diseases and others [7]. Specifically, impaired primary cilia on endothelial cells have important 
clinical consequences and are associated with many vascular diseases [8,9]. Although it has been 
over a century since primary cilia have been visualized, the study of their mechano- and chemo-
sensory roles remains relatively a new field of study. Additionally, studies on endothelial primary 
cilia function of the vascular system and primary cilia as a therapeutic target for vascular diseases 
are still limited. In this review, the roles of primary cilia will be discussed with emphasis on the 
cardiovascular diseases [10,11,12,13]. Hence, it is important to have a clear understanding about 
ciliary structure and functional ciliary proteins to investigate how cilia dysfunction can contribute 
to vascular disorders of hypertension, aneurysm and atherosclerosis. 
2.3 Cilia Structure  
A cilium is considered as a cellular organelle, which is primarily composed of a membrane, soluble 
compartment, axoneme, basal body, and ciliary tip [38]. A cilium extends from a basal body 
complex, which is mainly composed of two centrioles. One of the centrioles is known as the mother 
centriole, to which the ciliary axoneme is ingrained beneath the cell membrane. The cilium 
structure contains the microtubular portions of cytoskeletal core unit called the axoneme (Figure 
1). The axonemal structure contains nine peripheral doublet microtubules, which are made of 
alpha- and beta-tubulins and are post-translationally acetylated to support the long cilia structure 
[39,40,41]. The non-motile axoneme structure lacks the central pair of microtubules (9 + 0) 
[42,43]. In the blastocyst nodal cilia, the axoneme lacks the central pair of microtubules (9 + 0) 
but shows motility. This exception requires both dynein arms for motility [44]. Of note is that the 
lack of radial spokes induces rotational motion instead of beating motion, suggesting that the 
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absence of radial spokes allows nodal cilia to rotate unidirectionally but, as a trade-off, renders 
them ultrastructurally fragile [44]. While in most cases of motile cilia, the axoneme contains nine 
peripheral doublet microtubules and a central pair of microtubules (9 + 2) [45]. There is a 
connection between the microtubular portion of the cytoskeleton and the ciliary axoneme, and the 
disruption of cytoplasmic microtubules or actin filaments, which could affect microtubules 
assembly resulting in the loss of ciliary structural integrity and mechanosensory function 
[46,47,48]. On the other hand, protein entering and exiting through cilium is controlled by a 
proteomic barrier at the ciliary base that encompasses a transition zone which separates cytosol 
from the cilia [49,50,51,52]. The ciliary membrane is connected with the plasma membrane but 
possesses a lipid bilayer composition that differs from the plasma membrane compositions [53]. 
The periciliary membrane, also known as the transition-membrane, connects ciliary and plasma 
membrane to form the ciliary pocket [54,55]. In addition to its fundamental structural role, the 
basal body connected to the transition-membrane is thought to regulate protein entry and exit from 
the ciliary compartment. Furthermore, the mechanoreceptors, protein transporters, sensory 
proteins and ligand-gated ion channels are involved in signal transduction enclosed within the 
ciliary membrane. The axoneme allows the intraflagellar signaling and intraflagellar transport 
(IFT) activities along with ciliary shaft using the soluble compartment, also called cilioplasm. 
Primary cilium lacking ribosomes is incapable of producing its own proteins required for the 
elongation and continuous turnover of axoneme necessary for self-safeguarding. Moreover, each 
part of this cilia structure is crucial to support various signaling molecules. Some of the more 
established cilia-dependent signaling pathways are already described [38]. 
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Figure 2.1  Structure of primary cilium 
 
 
 
 
2.4 Primary Cilia as a Blood Flow Sensor 
Flow sensing by the cilia permit cells to sense blood flow along the blood vessels, urine flow 
through kidneys, bile acid in the liver, pancreatic secretions in the duodenum, nodal flow in 
A cilium is a membrane-bound structure and composed of multiple central pairs of microtubules 
(axoneme) running from the basal body. A basal body is a microtubule-based structure 
composed of mother and daughter centrioles. The ciliary membrane and axoneme contributes 
to the upper part of the cilium. The ciliary membrane is continuous with the cell membrane, but 
they have their own proteins, ion channels, and/or receptors. The ciliary skeleton may have 9 + 
0 or 9 + 2 axoneme compositions. Most 9 + 0 cilia lack inner and outer dynein arms, radial 
spokes, and central sheath and are commonly referred as non-motile primary cilia. Some 9 + 0 
cilia lack the central microtubule only and are motile. Between the cell membrane and cilium, 
there is a transition-membrane at the junction of the basal body acting as a barrier for molecules 
to enter or exit from the primary cilium.  
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Hansen’s node (the site which determines the patterns the anterior-posterior axis of the embryo 
during gastrulation), interstitial fluid flow within the bone canaliculi, and potentially other 
systems/organs [56]. The function of the vascular system depends on the mechanical fluid flow 
signaling from the blood flow. Several studies have also reported that the presence of primary cilia 
in major circulatory systems including endocardia [13,57], arteries [58,59], veins [60], corneal 
endothelium [61,62], and smooth muscle cells of both arterial and airway endothelia [63,64]. The 
continuous contraction and relaxation of smooth muscle cells produce changes in the blood vessels 
diameter, which is important for normal blood flow [65,66,67]. Increase in vascular stiffness is a 
major cause of hypertension, which leads to complications including ventricular hypertrophy, 
vascular aneurysm and atherosclerosis [68,69,70,71,72]. These changes suggest that smooth 
muscle cells or neuronal regulations are important in regulating the vascular tone in addition to the 
mechanical fluid-flow within the blood vessel. The regulation of circulatory function is acquired 
by neuronal regulators through central and/or peripheral neurons [73,74,75]. 
The mechanical fluid-flow provides local regulation or autoregulation within a blood vessel. For 
example, autoregulation is required to achieve immediate blood flow control in specified area of 
the tissue. Autoregulation is independent of the neighboring tissues and has little to no effect on 
the surrounding tissues [76,77]. In an isolated blood vessel, the sudden increase of transmural 
blood pressure causes a reduced vessel diameter [78,79,80], whereas high flow stress increases 
vessel diameter [67,80,81,82]. As such, the lining of the inner surface of vascular blood vessels 
are endothelial cells with primary cilia protrusions, which can sense changes in blood velocity and 
pressure and convert these mechanical signals into changes of vascular smooth muscle tone 
[83,84]. In a biophysical perspective, fluid-shear stress refers to the partial or frictional force of 
blood flow as it brushes against the vascular endothelia [85]. This frictional force is not stable 
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because blood flow changes with each heart muscle contraction, resulting in pulsatile patterns of 
blood flow [85]. As a result, blood flow through a vessel creates different types of forces such as 
stretch, compression, cyclic strain, pressure and shear stress. While these forces may be practically 
impossible to differentiate in vivo, they can be independently studied in in vitro and ex vivostudies 
[86]. 
Our earlier studies show that the primary endothelial cilia act as a mechanosensor in in 
vitro (mouse aortic endothelial cells), ex vivo (isolated mouse arteries, blood vessels from human 
patients) and in vivo (mouse models) [11,12,58]. Ciliary length is also positively correlated with 
mechanosensory action. Blood vessels with relatively a low fluid force have longer cilia while 
blood vessels with a high fluid force are devoid of cilia or have very short cilia. In addition, the 
changes in fluid dynamics affect endothelial cilia distribution and depend on fluid-flow intensity 
with longer cilia present in lower fluid-flow areas [13,87]. This is because of the inability of 
primary cilia to stand against high levels of fluid flow, which results in ciliary disassembly and 
loss of intraflagellar transport which is necessary for ciliary reassembly [88]. Subsequently, the 
mechanosensing function of cilia in high fluid flow areas could be replaced by other mechanisms 
like glycocalyx to sense higher shear forces [89]. 
Primary cilia have a critical role in sensing the extracellular stimuli, such as odorant or chemical 
(chemosensory) and movement (mechanosensory). These stimulations are then translated into 
intracellular signals. As a mechanosensor, a primary cilium can sense the fluid-flow in multiple 
cell types including renal epithelial and vascular endothelial cells [12,18,90]. Polycystin-1 (PC1) 
and polycystin-2 (PC2) form a mechanosensory complex in the primary cilia. It is recently shown 
that the PC1 and PC2 form a complex and are assembled in a stoichiometry of 3 PC2 for every 
PC1 molecule [91]. The PC1 and PC2 complex detects the bending of the cilia by the fluid flow 
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leading to an increase in Ca2+ influx and an inhibition of the regulated intramembrane proteolysis 
(RIP) of PC1 by keeping the signal transducer and activator of transcription (STAT) factor 6 and 
its coactivator P100 in a complex bound to PC1 tail [92,93]. This is how primary cilia is thought 
to promote proliferation and differentiation through fluid-shear stress. On the other hand, the 
absence or lack of flow as well as loss or dysfunction of cilia, PC1, or PC2 decrease Ca2+ influx 
and activate RIP that allows STAT6 and P100 to translocate to the nucleus and stimulate 
transcription resulting in uncontrolled cell proliferation and cyst formation [94,95]. In particular, 
PC1 and PC2 are widely expressed across the vasculature, and they are hypothesized to play a 
major role in the development, maintenance, and function of the myoelastic arteries [96,97,98]. 
These observations indicate a direct pathogenic role for both PC1 and PC2 in the vascular 
complications of hypertension, aneurysm and/or atherosclerosis. 
2.5 Role of Primary Cilia in Heart Development 
Nodal cilia probably have the earliest cilia function during embryonic development. During 
gastrulation period, both motile (nodal) and non-motile cilia at the embryonic node play an 
important role in regulating signaling cascades required for the formation of left-right asymmetry, 
a process which regulates the early stages of cardiogenesis and connection to the blood vessels 
[15,99,100,101,102]. Fluid flow plays an important role in trabeculation, cardiac cell proliferation, 
and formation of conduction system, in addition to changes in fluid-shear forces, which lead to 
cardiac diseases. Cilia in cardiomyocytes have a series of receptors, which take part in regulating 
cellular signaling mechanisms required for the continuous differentiation, morphogenesis and 
development of the heart [103,104,105,106]. Independent studies have established the important 
role of heart cilia in cardiac development. Defects in cilia structure or function lead to severe 
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inherited cardiac diseases. Also, defects in cilia result in a variety of heart developmental defects 
such as arterial and ventricular septum defects [107,108], abnormal looping, and remodeling of 
the heart tube into a multi-chambered organ [109,110,111,112,113,114] or myocardial wall 
disorganization [115]. Moreover, mice with a mutation in cilia structural 
gene ift88, kif3a or kif3b are characterized by severe heart phenotypes including hypoplasia of the 
endocardial cushions, a reduction in ventricular trabeculation, and an increase in volume of 
pericardial space including defective cardiac looping [102]. A variety of signaling pathways are 
involved directly or indirectly in heart development. For example, Hedgehog (Hh) signaling 
coordinated by primary cilia in a variety of cells controls tissue patterning and promotes the 
activation of different transcriptional factors involved in different cellular signaling mechanisms 
during homeostasis in vertebrates [116,117]. As a result, defects in primary cilia Hh signaling leads 
to severe cardiac disorders including congenital heart diseases [118]. Another example of a 
signaling pathway which plays an important role in cardiac morphogenesis is the superfamily of 
Transforming Growth Factorβ/Bone Morphogenic Protein (TGFβ/BMP). TGFβ/BMP signaling 
network is involved in a wide range of cellular mechanisms and processes and is therefore 
fundamentally vital during tissue homeostasis and morphogenesis [119]. Recent studies show that 
primary cilia can regulate the canonical TGFβ signaling network through the activation of 
transcription factors Smad2/3 at the ciliary pocket [104]. Furthermore, the TGFβ ligand, TGF-β1, 
stimulates the differentiation of stem cells into cardiomyocytes and that Ift88/Tg737 (Tg737orpk) 
mouse embryonic fibroblasts are characterized by decreased TGFβ activity associated with 
reduced clathrin-dependent endocytosis activity at the ciliary base, suggesting that cardiac primary 
cilia play a direct role in regulating TGFβ signaling during cardiomyogenesis. Recent findings 
further show that platelet-derived growth factor receptor-α (PDGFRα) localizes to primary cilia in 
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mutant mouse heart, indicating that a portion of the PDGF signaling pathway is associated with 
cardiac primary cilia during cardiac morphogenesis and development [105]. The localization of 
PDGFRα causes downregulation of Hh signaling in primary cilia and causes diminished 
ventricular wall thickness and ventricular septal defect [105]. Further, mice studies show that 
mutated or the absence of PDGFRα, consequences arise in prenatal mortality such as heart defects 
including weakened myocardium, thinned septa and valve, outflow tract, and aortic branch 
malformations [120,121,122]. Taken together, the PDGF signaling system might be specifically 
coordinated by cardiac primary cilia, potentially acting as signaling hubs facilitating the cross-talk 
between different signaling networks in order to coordinate cardiogenesis. 
2.6 Role of Primary Cilia in Biochemical Signaling and Hypertension		
As mechanosensory organelles, primary cilia depend on various receptors expressed on the ciliary 
membrane. Vascular endothelial cells lining the blood vessel wall are in continuous contact with 
blood flow forces. Activation of primary cilia by blood flow leads to the activation of PC1 and 
PC2 resulting in an intracellular Ca2+ signaling network involving calmodulin (CaM), calcium-
dependent protein kinase (PKC), serine-threonine kinase/protein kinase B (Akt/PKB) and 
endothelial nitric oxide synthase (eNOS). Such biochemical reaction generates nitric oxide (NO) 
leading to vasodilation (Figure 2). There are two major proposed mechanisms for primary cilia 
detection of blood flow forces [85]. The first suggests that ciliary bending occurs upon exposure 
to blood flow-pressure force, which triggers cytoskeletal distortion. The second suggests that cilia 
bending triggers activation of PC1 mechanosensory protein and PC2 cation Ca2+ channels. It is 
proposed that the increase in intracellular Ca2+ is caused by an increase in intraciliary Ca2+ [123], 
whereas another study has suggested that Ca2+ could be rallied in both directions between the cilia 
and the cytoplasm [124]. While differences in the intraciliary Ca2+ can be due to the sensitivity of 
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the cilia-specific Ca2+ probes [125], both studies show a consensus that mechanosensing function 
of cilium involves cytosolic Ca2+ signaling as shown independently by other laboratories 
[17,126,127]. Thus, it is fair to assess that primary cilia are Ca2+-responsive mechanosensors that 
can trigger a diverse biochemical signaling. 
Regardless, the cytosolic Ca2+ forms complexes with CaM, and the Ca2+-CaM complex has been 
shown to indirectly activate eNOS through activation of the AKT/PKB signaling which activates 
AMPK, a known stimulator of eNOS [128]. Inhibition of Ca2+-dependent PKC, Akt/PKB, or CaM 
activity downstream of Ca2+ signaling have no effect on the flow induced intracellular 
Ca2+ increase, although there is a loss of NO synthesis [11]. This indicates that the Ca2+ signaling 
is upstream of the biochemical reaction in producing NO. Though eNOS triggering is principally 
a Ca2+-dependent process, some studies have suggested a Ca2+-independent pathway in NO 
biosynthesis is also possible. This Ca2+-independent pathway depends on the heat shock protein 90 
(HSP90) [129,130]. HSP90 is a molecular chaperone, but it may also act as a signal transduction 
agent concomitant with eNOS in several systems, including the cardiovascular system. HSP90 
also localizes to primary cilia [131]. Although its activation can increase eNOS action in presence 
of Ca2+-CaM [129,132,133], it is unclear if cytosolic HSP90 is involved in this signaling pathway. 
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Figure 2.2  Vascular endothelial cilia sense the blood flow along the blood vessel. 
 
 
 
Primary cilia are structural compartments that house many mechanosensory proteins. Ciliary 
bending occurs upon blood-flow stimulation, and polycystin-1 (PC1) activates polycystin-2 
(PC2), resulting in calcium (Ca2+) influx. This generates a cascade of various protein 
activation and ultimately leads to endothelial nitric oxide synthase (eNOS) activation, 
producing vasodilator nitric oxide (NO). Calmodulin (CaM), calcium-dependent protein 
kinase (PKC) and serine-threonine kinase/protein kinase B (Akt/PKB) are involved in 
maintaining a healthy vascular structure. Abnormality in primary cilia has been proposed to 
promote vascular atherosclerotic formation.  
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Dopamine signaling is considered to be an important signaling mechanism in the nervous, immune, 
cardiovascular, and renal systems [134]. Dopamine is an endogenous catecholamine hormone that 
is mainly produced in the brain and adrenal gland and is also biosynthesized in renal proximal 
tubules [135,136,137]. Dopamine, an endogenous hormone in the sympathetic nervous system, is 
known to be intricated in the regulation of hypertension. For example, abnormalities in dopamine 
signaling can contribute to high blood pressure in humans. The five G-protein-couple dopamine 
receptors (DR) are categorized into D1-like (DR1 and DR5) and D2-like (DR2, DR3, and DR4) 
families. Several in vitro and in vivo experiments confirm the presence of Dopamine 1-like 
receptors, DR1 and DR5, on primary cilia [59,138,139,140,141]. Studies have identified DR5 
receptors in cultured mouse vascular endothelial cilia and mouse arteries in vivo. The DR 
modulates cilia mechanosensory function by altering fluid flow sensitivity. Rat studies also show 
that dis-integrin and metalloproteinase with thrombospondin motifs 16 (Adamts16) play a crucial 
role in blood pressure control. Further, interruption of the Adamts16 gene results in longer vascular 
endothelial primary cilia and significantly lower systolic blood pressure [58]. To date, there are no 
drugs available that specifically target DR in the cilia, but studies using agents selective for DR1-
like receptor subtypes have shown vasodilatory outcomes in peripheral arteries. Activation of DR5 
using dopamine increases ciliary length while inhibition of DR5 leads to the loss of ciliary sensory 
(chemo and mechano) activity [59]. These results are confirmed by challenging endothelial ciliary 
knockout cells, Pkd1−/− and no or short cilia Tg737orpk/orpk with dopamine under static conditions, 
resulted in a considerably less Ca2+ influx than wild-type endothelial cells. As Ca2+ fluxes in these 
cells are often concomitant with activation of eNOS, the results may indicate a potential 
reestablishment of the missing vasodilatory reactions caused by a failed ciliary generation of NO 
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biosynthesis. Likewise, there are DR within blood vessels in human, and activation of DR triggers 
a vasodilatory action [142]. 
Cilia dysfunction causes abnormal Ca2+ signaling and kidney disorders such as autosomal 
dominant polycystic kidney disease (ADPKD), which is a genetic disease caused by a mutation in 
ciliary PC1 or PC2 [6]. Cardiovascular malformations including high blood pressure and left 
ventricular hypertrophy notably contribute to mortality in ADPKD patients. A recent clinical 
review involving 1877 ADPKD patients shows that the use of antihypertensive medications in 
ADPKD patients have been increased from 32% in 1991 to 62% in 2008 [143]. This has important 
clinical consequences as another study has found that border-line hypertension in ADPKD patients 
show a better response with a dopamine precursor relatively to the angiotensin-converting enzyme 
inhibitor [144]. When individuals are perfused with 0.25–0.5 μg/kg/min of dopamine, the results 
indicated an upward trend in flow-mediated dilation in ADPKD patients and reported a statistically 
significant decrease in hypertension [145]. It is currently studied to better understand if the 
dopamine-induced vasodilation is a cilia-dependent process [146]. A more recent study, however, 
seems to support the idea of cilia involvement in hypertension [147]. The study shows that cilia 
function is impaired in endothelial cells from patients with pulmonary arterial hypertension due to 
the inflammation, and cilia length plays an important role in response to inflammatory signaling, 
such as pro-inflammatory cytokines and/or anti-inflammatory interleukins. The results show that 
the pro-inflammatory cytokines help in increase cilia length and is PKA/PKC-dependent, whereas 
anti-inflammatory interleukins induce a reverse effect on cilia length. It is therefore postulated that 
the length of endothelial cilia is associated with endothelial function and pulmonary arterial 
pressure. 
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2.7 Role of Primary Cilia in Vascular Aneurysm 
An aneurysm is a formation of an abnormal swelling in a weak area of a blood vessel that can 
rupture, leading to bleeding and possibly to death. The most common arteries that can be affected 
by aneurysm are cerebral arteries and aortic artery. Aneurysm formation and rupture are 
considered one of the major complications associated with ADPKD, in which PC1 is required for 
structural integrity of blood vessel [148]. Thus, PC1 and PC2 functions are required in blood 
vessels [97,98,149], and, any abnormalities in either protein leads to aneurysm formation [150]. 
Of note: In ADPKD patients, the aneurysm can occur in different arteries such as the aorta, splenic, 
coronary, and cerebral arteries [151,152,153,154]. 
Within the arteries, primary cilia play an important role in the structure and the function of 
endothelial cells [12,60]. Therefore, the absence or dysfunction of primary cilia can induce 
aneurysm formation and progression during vascular injuries [10,155]. Vascular aneurysms are 
associated with tissue remodeling due to unusual proliferation of the endothelial cell layers through 
the hemodynamic fluctuations in fluid-shear forces [156]. Endothelial cilia are required for shear 
stress-induced Ca2+ influx and NO signaling [11], and eNOS deficiency is the hallmark of 
endothelial dysfunction and associated with cardiovascular complications including aneurysm, 
indicating the protective role of eNOS [157]. Primary cilia regulate endothelial actin organization 
and focal adhesion assembly that can affect directional migration and cell permeability through 
hsp27 and Notch/foxc1b signaling [158,159]. It is therefore thought that the mechano-sensation of 
primary cilia is essential in promoting proper vascular development. 
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Previously, we showed that the similarity of the pathogenesis between cyst formation and 
aneurysm associated with PKD in mice models 
(PdgfβCre:Survivinflox/flox, PdgfβCre:Pkd1flox/flox and PdgfβCre:Tg737flox/flox). Dysfunction of the 
primary cilia induces an abnormal survivin expression that results in irregular cytokinesis leading 
to cell polyploidy, multi-mitotic spindle formation and aberrant cell division orientation. This 
abnormality in symmetrical cell division and cell ploidy leads to the extension of tissue 
architecture, developing cysts in the kidney and aneurysm in the vasculature [10]. PKC and Akt 
are downstream signaling messengers of primary cilia, and they regulate survivin expression 
following primary cilia activation. Akt is downstream of PKC and can regulate Nuclear Factor-
κB, which regulates the expression of survivin. All in all, the inability of primary endothelial cilia 
to respond to fluid flow can contribute to the vascular aneurysm. 
2.8 Role of Primary Cilia in Atherosclerosis 
Atherosclerosis plaques mainly develop in the arterial system with bifurcations, branch points, or 
the inner curvature of arched arteries. Atherosclerosis plaques are often observed at sites with low 
and oscillating fluid-flow within the embryonic cardiovascular system [13,57]. Plaques happen 
most frequently in areas of great curvature and branch points in addition to low fluid forces or non-
unidirectional flow [160,161]. Like cilia which are present only at the regions of inner curvature 
of the artery arch [13], atherosclerotic plaques do not happen homogenously along the circulatory 
system. A recent report confirms that removing endothelial cilia from the vascular branch points 
causes abnormal fluid-flow responses that contribute to the atherosclerosis [162]. Moreover, 
exposure of endothelial cells to oscillatory fluid-flow results in the disengagement of eNOS, which 
promotes reactive oxygen species (ROS) formation rather than NO, leading to atherosclerosis 
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plaque growth [163]. There is an upregulation of inflammatory gene expression in areas with 
disturbed blood flow, and this further promotes plaque formation and hyperlipidemia [164,165]. 
The role of primary cilia in the development of atherosclerosis has been revealed in the 
apolipoprotein-E-deficient mouse model (Apoe−/−) with a high fat and cholesterol diet [162]. 
Increasing numbers of the endothelial primary cilia existed in atherogenesis areas under 
hyperlipidemia-induced lesion formation. Tek-Cre•Ift88C/−•Apoe−/−, in which endothelial Ift88 was 
specifically ablated, displayed a significantly greater increase in plaque formation compared to 
that established by their wildtype littermates. The lack of endothelial cilia in vascular branches 
result in significant upregulation lymphocyte markers, macrophage marker genes, along with 
proinflammatory cytokines [162]. Atherosclerosis lesions increase in the mice who lack 
endothelial cilia by 59% in females, and 67% in males as compared to the control mice. This is 
measured by counting atherosclerotic lesioned surface area. Furthermore, lacking endothelial cilia 
enhances inflammatory gene expression and a decrease in endothelial nitric oxide synthase 
activity. Hence, it is proposed that vascular endothelial cilia play an important role in control of 
atherosclerosis. 
2.9 Role of Primary Cilia in Cell Proliferation 
Not only do primary cilia provide a sensory signaling hub, they also play an important role in cell 
proliferation. Ciliogenesis begins at the G1/G0 phase of the cell cycle, and resorption or 
disassembly of cilia starts after the cell cycle re-entry. Primary cilia formation is influenced by the 
coordination of assembly/disassembly equilibrium, IFT system, and membrane trafficking [166]. 
Specifically, ciliogenesis involves multiple steps and is correlated with cell division. First, the 
centrosome travels to the cell surface and the basal body is formed by the mother centriole to 
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nucleate ciliary axoneme at the G1/G0 phase of the cell cycle. This step which involves membrane 
docking is regulated by the distal appendage proteins, such as centrosomal protein 164 (Cep164). 
On the other hand, CP110, Ofd1, and trichoplein are negative regulators of ciliogenesis targeting 
ciliary extension. Second, elongation of the cilium and maintenance of ciliary length occur. This 
process is negatively regulated by Nde1 until mature primary cilium is formed. Third, upon cell 
cycle entry, ciliary resorption occurs followed by axoneme shortening. Ciliary disassembly is 
controlled by Aurora A-HDAC6, Nek2-Kif24, and Plk1-Kif2A pathways. Fourth, the basal body 
is released from cilia; thus, centrioles (centrosome) become free to act as microtubule organizing 
center (MTOC) or spindle poles during mitosis [166,167,168]. 
In tumors, cilia are not present on most proliferative cells suggesting that although cilia are not 
directly required during cell proliferation, they do play a key role in the entry and exit of mitosis 
[169,170,171]. PC1 has been shown to mediate JAK/STAT pathway [172]. Ciliary PC1 is able to 
activate STAT3; when the cytoplasmic tail of PC1 is cleaved in response to fluid-flow, it can 
coactivate STAT-1, 3, and 6 as well as JAK2 [92]. The PC1 tail triggers several cytokines and 
growth factor signaling, amplifying the cellular response and potentially leading to an increase in 
L-arginine thus arresting cell proliferation. 
Although the reason of the absence of cilia in cancer cells is not exactly known, this phenomenon 
is arguably not surprising given that the presence of cilia is a cell-cycle-dependent process [173]. 
Thus, cilia are not expected to be present in highly proliferative cells. However, what complicates 
the discussion is that primary cilia have also been reported in cancers, including in 
medulloblastoma [34,174], basal cell [33] and gastroinstestinal stroma cells [175]. A recent study 
suggests a possibility of an enzymatic effect in cancer cells [176]. It is shown that posttranslational 
modification of ciliary tubulin is affected and resulted in less robust formation of primary cilia. 
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Lacking proper posttranslational modification in ciliary exoneme may therefore increase a risk 
factor for cancer development [176]. 
2.10 Conclusion and Perspectives 
Both primary cilia structure and sensory functions are essential for normal tissue homeostasis and 
function. The in vitro and ex vivo fluid-flow studies have greatly advanced our knowledge of the 
chemo- and mechano-sensory function of primary cilia in cardiovascular systems. More studies 
are warranted towards clinical intervention for hypertension, aneurysm and atherosclerosis. 
Unfortunately, there are no pharmacological agents available that selectively target primary cilia. 
While this review mostly represents a small portion of possible connections between primary cilia 
and cardiovascular disorders, we may need a large-scale screening study to include potential 
pharmacological agents in order to understand whether or not targeting sensory functions of 
primary cilia would result in better cardiovascular outcomes. 
Primary cilia are ubiquitously present in many organ systems, including the cardiovascular system. 
Emerging data suggest that cilium dysfunction is a primary cause in many cardiac and vascular 
disorders. Over the past years, researchers have provided tremendous advances in understanding 
of the basic cellular and molecular functions of primary cilia. Despite the fact that more research 
is needed, we should also extend ourselves by integrating the basic science knowledge into clinical 
considerations and perspectives. Otherwise, we are not able to see the forest because we are too 
focused on the trees. 
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3.1. Abstract 
Primary cilia are sensory organelles that regulate cell cycle and signaling pathways.  In addition 
to its association with cancer, dysfunction of primary cilia is responsible for the pathogenesis of 
polycystic kidney disease (PKD) and other ciliopathies.  Because the association between cilia 
formation or length and cell cycle or division is poorly understood, we here evaluated their 
correlation in this study.  Using Spectral Karyotyping (SKY) technique, we showed that PKD and 
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the cancer/tumorigenic epithelial cells PC3, DU145, and NL20-TA were associated with abnormal 
ploidy.  We also showed that PKD and the cancer epithelia were highly proliferative.  Importantly, 
the cancer epithelial cells had a reduction in the presence and/or length of primary cilia relative to 
the normal kidney (NK) cells.  We then used rapamycin to restore the expression and length of 
primary cilia in these cells.  Our subsequent analyses indicated that both the presence and length 
of primary cilia were inversely correlated with cell proliferation.  Collectively, our data suggest 
that restoring the presence and/or length of primary cilia may serve as a novel approach to inhibit 
cancer cell proliferation. 
 
Figure 3.1  Graphical Abstract 
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3.2. Introduction  
Most of the non-hematological cells in humans display sensory primary cilia, which are expressed 
on the cell surface [1].  Primary cilia act as antennae that transmit extracellular signals into 
intracellular biochemical responses. Primary cilia regulate cell signaling and key cellular 
processes, such as proliferation, differentiation, and migration [2-5].  Genetic mutations that 
disrupt the function of primary cilia can therefore result in a diverse set of diseases called 
ciliopathies.  These disorders involve not only rare congenital syndromes like Joubert syndrome, 
Bardet-Biedl syndrome, and Meckel syndrome, but also more common diseases such as polycystic 
kidney disease (PKD) [6-10].  Furthermore, cancer has been proposed as a ciliopathy [11].  The 
most essential role of cilia in cancer pathogenesis is presumably its regulation on cell cycle and 
malignancy-related signaling pathways [12-14]. 
The structure of the cilium can be divided into 3 parts: the basal body, the axoneme, and the 
transition zone.  The timing of cilium formation or ciliogenesis is controlled by the phases of cell 
cycle [15, 16].  Formation of primary cilia typically begins at the G1/G0 phase of the cell cycle 
when the mother centriole in the centrosome acts as a basal body to start cilia formation [17, 18].  
As cells re-enter the cell cycle, the cilium and the basal body disassembled releasing the centrioles 
to work as the organizing center for the mitotic spindles during cell division [19, 20].  As the cells 
enter the quiescence or resting phase, the mother centriole forms the basal body and the primary 
cilium re-assembled.  According to this finding [18, 21], primary cilia develop only in quiescent 
or differentiated cells; therefore, as the proliferation index increases, the number of ciliated cells 
decrease [22].  Thus, cilium has been hypothesized to regulate the cell cycle and is thought to halt 
abnormal cell growth by restricting cell cycle [16]. 
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Previous studies report reduction or loss of primary cilia in a variety of cancer types, such as 
pancreatic cancer, renal cell carcinoma, breast cancer, and cholangiocarcinoma [7, 9, 23, 24].  Loss 
of the primary cilia in cancer cells may induce cell proliferation and may also participate in 
abnormal cellular signaling associated with cancer or its formation.  Jenks et. al. recently report 
that enhanced ciliogenesis can facilitate resistance to a number of kinase inhibitors [25]. They 
show that both acquired and de novo resistant cancer cells show an increase in cilia number, and 
length.  Based on the collective evidence and observations, we thus hypothesize that cilia length 
is associated with cancer progression, and specific pathways in cilia associated with cancer cell 
cycle can be modulated. 
The major ciliary signaling pathways include the Hedgehog [14], Wnt [26] and Platelet-Derived 
Growth Factor [27].  In particular, Wnt signaling pathway modulates the balance between cellular 
differentiation, polarity controls and proliferation to regulate tissue homeostasis [1, 28].  The 
presence of primary cilium controls the expression levels of Wnt target genes by regulating the 
degradation of Disheveled (Dvl), a protein that is recruited to the membrane and binds axin to 
prevent b-catenin degradation.  Specifically, inversin and nephrolithiasis-3 localized in the primary 
cilium are involved in the regulation of Dvl level [26, 29].  In addition, sequestering ciliary protein 
AHI1 to the cilium has been shown to prevent β-catenin to translocate into the nucleus [30]. 
In this study, we characterized the presence and the length of primary cilia in human cancer cells.  
We also examined the correlation between primary cilia expression and Wnt signaling pathway.  
We showed that primary cilia presence and length are reduced in cancer.  Moreover, we 
demonstrated that this loss of primary cilia is associated with an increase in the baseline b-catenin 
level as a measure of Wnt signaling.  Because recent studies have shown that cilia length in 
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vascular endothelia and renal epithelia of normal and cancer tissues can be regulated 
pharmacologically [31, 32], we further aimed to restore primary cilia expression in cancer cells 
using sirolimus (or rapamycin).  Our goal was to understand the relationship among Wnt signaling 
pathway, cell proliferation and primary cilia. 
3.3. Materials and Methods 
Cell Lines and Culture Conditions 
Only human epithelial cells were used in our studies.  Both normal kidney (NK) and PKD2 cells 
with abnormal cilia function (PKD) have been previously characterized [33, 34].  NK has fully 
functional primary cilia, while PKD is a well-known model for dysfunctional cilia; thus, we used 
them as controls in our study.  Human prostate cancer cells PC3 (ATCC CRL-1435) [35], DU145 
(ATCC HTB-81) [36] and bronchial tumorigenic epithelial cells NL20-TA or NL (ATCC CRL-
2504) [37] were obtained from the American Type Culture Collection (ATCC, Manassas, VA).  
We used these epithelial cells to obtain independent correlation between hyperproliferation and 
cilia length or cilia formation in the presence or absence of rapamycin (AK Scientific, Union City, 
CA) treatment.  Thus, the presence studies were to examine if there was a correlation in the changes 
between hyperproliferation and cilia length or cilia formation using these human epithelial cell 
lines.  Cells were supplied with epithelia growth medium (PromoCell, Heidelberg, Germany) 
supplemented with 15% fetal bovine serum (FBS; Seradignm, Radnor, PA), and were maintained 
in 5% CO2 at 37°C under humidified culture conditions.  In the experiments that cell confluence 
was required to induce cilia formation, the cultured cells were incubated with media containing 
2% FBS and 0, 1 or 10 µM of rapamycin for 1, 3, and 8 days [31, 32, 38].  For the 8-days treatment, 
the media and rapamycin were replaced with the fresh preparation on the fourth day. Both 
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concentrations and durations of rapamycin treatment had also been used in previous studies [31, 
32]. 
 Spectral Karyotyping (HiSKY) 
We have previously described this methodology in detail [39].  Briefly, after the cells were grown 
to 60-70% confluent, 0.05 μg/ml of colcemid solution (Adipogen, San Diego, CA) was added to 
the cells and incubated for 48 hours.  After harvesting the cells, they were incubated with a 
hypotonic solution (0.56% KCl) followed by a fixing solution (methanol/acetic acid). KCl, 
methanol and acetic were purchased from Fisher Scientific (Fair Lawn, NJ). The chromosomes 
were next spread on a slide and hybridized with a cocktail of human fluorescence-labeled probes 
specific for individual chromosomes (Applied Spectral Imaging, Carlsbad, CA).  Data were 
analyzed with the HiSKY Spectral Imaging system from Applied Spectral Imaging.   
Immunofluorescent Staining 
While cilia may lose some of their structural integrity upon fixation, certain fixation techniques 
can preserve the substructure of primary cilia and ciliary proteins [40, 41]. Selecting a proper 
fixation method depends on which ciliary proteins are of interest to the investigators. Generally, 
proteins that are localized along the axoneme are best preserved with paraformaldehyde fixation. 
Since axoneme is a microtubule-rich structure that forms the core of primary cilia, antibodies 
against acetylated-a-tubulin can be used to detect axoneme. Paraformaldehyde fixation (10-min 
incubation at room temperature) provides a replicable result, maintains an intact microtubule 
cytoskeleton, and preserves the cytoskeletal labeling. The same technique was therefore used in 
our study to maintain consistency with what was already established in the cilia field [40, 41]. 
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Briefly, cells were seeded onto coverslips placed in six-well plates.  After the cells have reached 
the required confluency (60-70%), they were cultured for the various time points in maintenance 
medium with or without rapamycin.  The cells on the coverslips were then subjected to a 10 
minute-fixation using 4% paraformaldehyde (EMS, Hartfield, PA) and 2% sucrose (Fischer 
Scientific, Fair Lawn, NJ) in phosphate-buffered saline (PBS; Corning, Manassas, VA).  After a 
PBS wash, the cells were permeabilized using 1% TritonX (Fischer Scientific, Fair Lawn, NJ) in 
PBS.  Acetylated-a-tubulin antibody (1:10,000 dilution, Sigma Aldrich, St. Louis, MO; catalog# 
T6793) was added to the primary cilia and incubated overnight at 4oC followed by a 1-hour 
incubation at room temperature with fluorescein isothiocyanate (FITC)-conjugated anti-mouse 
IgG secondary antibody (1:1000 dilution, Vector Labs Burlingame, CA; catalog# Fl-2000; lot# 
ZE0803).  Actin filaments were stained by incubating the cells for 1 hour at room temperature with 
Texas Red-conjugated phalloidin (1:400 dilution, Invitrogen, Carlsbad, CA; catalog# T7471, lot# 
23749W).  Nuclei were stained with mounting media containing Dapi blue fluorescence (Vector 
Labs Burlingame, CA).  The images of the primary cilia were captured by a fluorescence 
microscope, and their presence and length were analyzed by NIS-Elements software. 
Cell Growth 
To quantify their growth rate of cells, cells were counted every day for 5 days.  On day 0, 3x105 
cells were seeded and plated on 10 cm culture dishes supplied with growth medium.  The evenly 
distributed cells in each dish were then counted every 24 hours until they were 100% confluent.   
Cell Cycle and Proliferation Analyses 
After harvesting the cells using trypsin (Corning, Manassas, VA), the cells were fixed using 95% 
ethanol and incubated at -20oC overnight.  In some experiment, cells were first labeled with 10 
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µM bromodeoxyuridine/fluorodeoxyuridine (BrdU; Acros Organics, Pittsburg, PA; catalog# 
AC228595000) for 1 hour at 37oC and 5% CO2.  For DNA denaturing, the cells were incubated 
with 2N HCl for 30 minutes at room temperature followed by neutralization with 0.1 M sodium 
borate for 30 minutes at room temperature.  Afterwards, the cells were incubated with Alexa 488 
conjugated BrdU antibody (Invitrogen, Carlsbad, CA; catalog# A21305, lot# 571730) for 1 hour 
at room temperature in the dark for BrdU experiments.  In other experiments, the cells were stained 
with propidium iodide (PI) for 1 hour at room temperature in the dark.  Cells were then analyzed 
with flow cytometry BDFacsverse. 
Western Blot Analysis 
Cells were lysed using lysis buffer (Thermoscientific, Rockford, IL) supplemented with protease 
inhibitor cocktail (Complete, Mannheim, Germany).  The concentrations of protein were 
determined by using micro bicinchoninic acid assay (BCA) (Thermoscientific, Rockford, IL).  A 
30 µg of protein was prepared using 2x Laemmli sample buffer (BioRad, Hercules, CA) and loaded 
on a 10% SDS-polyacrylamide gel.  The gel was run for 1-2 hours at 120V.  After transferring the 
protein from the gel to the membrane (BioRad, Hercules, CA), the membrane was blocked with 
5% non-fat dry milk (Lab Scientific, Livingston, NJ) for 2 hours at room temperature.  The 
membrane was then incubated overnight at 4°C with primary antibodies specific for Gli1 Anti-
Gli1 antibody (Abcam, Burlingame, CA; catalog# ab49314) [42], smo (LSBio, Seattle, WA; 
catalog# LS-A2666-50) [43], b-catenin (Abcam, Burlingame, CA; catalog# ab6302, lot# 
GR3314727-5) [44], phospho-mTOR (Ser2448) (Cell Signaling Technologies, Danver, MA; 
catalog #2976, clone# 49F9) [45], phospho-mTOR (Ser2481) (Cell Signaling Technologies, 
Danver, MA; catalog #2974) [45], phospho-p70 S6 Kinase (Thr389) (Cell Signaling Technologies, 
 
60 
Danver, MA; catalog# 9234) [46] and b-actin (Cell Biolabs, San Diego, CA; catalog# AKR-002). 
Afterwards, the membrane was incubated with secondary anti-rabbit (catalog# 7074) or anti-
mouse (catalog# 7076) HRP-linked antibody (Cell Signaling Technologies, Danver, MA) for 1 
hour at room temperature.  The signals were analyzed by an imager (BioRad, Hercules, CA) after 
the membrane was subjected to SuperSignal West Pico PLUS Chemiluminescence Substrate 
(Thermoscientific, Rockford, IL; catalog# 34580, lot# UH290793). 
β-catenin immunofluorescence 
To differentiate nucleus and cytoplasmic β-catenin, cells were plated onto coverslips placed in six-
well plates and allowed to grow to 50-70% confluency before treatments.  After cells were treated 
for the different time points (0, 1, 3 and 8 days) in maintenance medium with or without rapamycin, 
cells were fixed using 4% paraformaldehyde and 2% sucrose in PBS for 10 minutes.  For the 8-
days treatment, the media and rapamycin were replaced with the fresh preparation on the fourth 
day.  Cells then were washed with PBS and permeabilized using 1% TritonX in PBS.  Next, cells 
were incubated with anti-b-catenin primary antibody (1:2000) at 4oC overnight followed by a 1-
hour incubation at room temperature with FITC-conjugated anti-rabbit IgG secondary antibody 
(1:1000 dilution, Vector Labs Burlingame, CA; catalog# Fl-1000, lot# ZC0202).  Nuclei were 
stained with mounting media containing Dapi blue fluorescence.  Images were acquired using NIS-
Elements software.  For analysis, all images were viewed and randomly captured at 100× 
magnification.  For quantification, cells were counted from three different microscopic fields.  A 
region of interest (ROI) was randomly selected in the nucleus and cytoplasm.  The ratio of FITC 
fluorescence in nucleus versus cytoplasm was determined by measuring the FITC fluorescence of 
the ROI in the nucleus and cytoplasm.  
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Data and Statistical Analysis  
We used NIS-Elements software (version 4.3), Microsoft Excel (version 16.32), and GraphPad 
Prism (version 8.3) to analyze the presence and length of primary cilia.  Whenever feasible, the 
data was confirmed to be normally distributed prior to the subsequent analyses.  Otherwise, the 
data were transformed logarithmically.  The slope of the growth curve was measured by fitting the 
curve into the sigmoidal-fitted graph.  For Western blot analysis, band intensity was captured with 
Bio-Rad imager (Model no. Universal Hood III. Serial no. 731BR02716. version 5.1), quantified 
with the NIH Fiji ImageJ (version 2.0), and analyzed with GraphPad.  For all studies, a minimum 
of three independent experiments were performed.  The exact number of independent experiments 
for each study is indicated in the scattered bar graphs or in the figure legends. 
The correlation analyses were performed by using Pearson correlation coefficient test.  Multiple 
variable analyses were further performed by using multiple-linear regression test.  The Pearson 
correlation was studied before and after rapamycin treatment with 1-dimensional (before vs. after 
of one variable) or 2-dimensional (before vs. after of two variables) analysis.  To clarify the 
correlation analyses, scattered plots (before vs. after) were provided to show the strength and 
weakness of Pearson correlation coefficient.  For the 2-dimensional analysis, the correlation for 
the variables (slope) was first identified before (or after) treatment followed by the correlation 
before vs. after analysis in the corresponding scattered plot. 
All data were reported as mean±standard error of mean (SEM).  A p value of <0.05 was considered 
statistically significant.  Statistical analysis comparing multiple groups was performed by using 
ANOVA test followed by Tukey’s post-test or Dunnet post-test.  Significant differences relative 
to the control baseline within each group are indicated in asterisk (*). Differences with normal 
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kidney (NK) epithelia are indicated in a hash sign (#).  The level of significant difference (p value) 
is indicated in each graph and figure legends. 
 
3.4. Results 
PKD and Cancer Cells were Characterized by Abnormal Ploidy.  
Because genomic instability has been associated with dysfunction of primary cilia [33, 47-49], we 
studied chromosome numbers in PKD and cancer cells using SKY technique to authenticate our 
cells.  Karyotyping analyses revealed that NK had a normal chromosomal composition (Fig. 2.2A).  
In contrast, PKD had abnormal ploidy (77,XX) (Fig. 2.2B). PC3 karyotyping analysis also showed 
abnormal ploidy (104,XY) (Fig. 2.2C).  The abnormal polyploidy was also apparent in DU145 
(72,XY) (Fig. 2.2D). Karyotyping analysis of NL showed an abnormal increase in the number of 
chromosomes (109,XX) (Fig. 2.2E).  Overall, karyotype analysis of individual cells confirmed that 
the abnormal ploidy was associated with PKD and cancer cells (Fig. 2.2F).  The chromosomal 
spread for each representative image is shown (Fig. 2.3).  A more specific ploidity of each 
chromosome of each cell type is also presented (Table 2.1).  
Primary Cilia Expression was Decreased in Cancer Cells.  
To characterize the expression of primary cilia in different cell types, the presence of cilia was 
determined by immunofluorescence using antibody against acetylated-b-tubulin (Fig. 2.4A).  
Actin filaments was stained with phalloidin and nuclei were stained with DAPI to simply identify 
individual cells.  The representative images show that primary cilia were expressed in NK, PKD, 
and PC3, but they were absent in both DU145 and NL (Fig. 2.4B).  Even though cilia were present 
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in PC3, the percentages of the primary cilia were significantly lower than those observed in NK.  
However, there was no significant difference in cilia length among NK, PKD, and PC3.  The 
distribution of cilia lengths in each cell type was tabulated (Fig. 2.4C). 
 
PKD and Cancer Epithelia were Highly Proliferative. 
Since primary cilia play an important role in cell cycle regulation [16], we assessed the 
proliferation profile of each cell type.  The growth rates of the five cell types over a period of five 
days were examined by counting the cell number every day (Fig. 2.5A).  The growth rates were 
significantly higher in PKD and cancer cells than NK cells.  We also assessed the proliferative 
index by examining the DNA contents because some of the cancer cells continued to divide even 
after they have become confluent.  The relative percentage of cells in each phase (G1 and G2/M) 
was quantified and analyzed with flow cytometry.  The post-analysis graphs (Fig. 2.5B) and pre-
analysis histogram (Fig. 2.6) from flow cytometry studies are presented.  In confluent condition, 
the percentage of the cells in the G2/M phase was significantly higher in PC3 and DU145 than NK.  
This effect was associated with lower percentage of PC3 and DU145 cells in the G1 phase.  In non-
confluent condition, there was a significant increase in the accumulation of the cells in the G2/M 
phase and a significant decrease in the accumulation of the cells in the G1 phase in PKD, PC3, 
DU145, and NL cells compared to NK.  Our data indicated that compared to control normal NK 
cells, both PKD and cancer epithelia had higher proliferative rate. 
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Figure 3.2  Karyotyping analyses of human epithelial cells.   
 
Spectral karyotyping shows somatic chromosomes (1 to 22) with a pair of sex chromosomes (XY).  
Representative images show epithelium from (A) normal kidney (NK) with normal chromosome number 
(46, XY), (B) PKD (77,XX), (C) PC3 prostate cancer (104,XY), (D) DU145 (72,XY), and (E) NL 
(109,XX).  (F) Summary of overall karyotype analysis of individual cells confirmed the abnormal ploidy 
associated with PKD and cancer cells. N=10-12 for each cell type. 
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Figure 0.3  Representative images of metaphase spread.   
Shown here are images in brightfield (on the left) and 
pseudocolored (on the right) of NK, PKD, PC3, DU145, and 
NL. 
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Table 0.1  Chromosomal abnormality (frequency) in epithelia 
Chromosome 
number NK PKD PC3 DU145 NL 
1 Normal Polyploidy / Aneuploidy (9/11) Normal Normal 
Polyploidy 
(10/10) 
2 Normal Polyploidy / Aneuploidy (9/11) 
Polyploidy / 
Aneuploidy (10/12) 
Polyploidy 
(10/10) 
Polyploidy / 
Aneuploidy 
(10/10) 
3 Normal Normal Polyploidy / Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
4 Normal Polyploidy / Aneuploidy (9/11) 
Polyploidy / 
Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
5 Normal Polyploidy (9/11) Polyploidy / Aneuploidy (10/12) Normal Normal 
6 Normal Normal Polyploidy / Aneuploidy (10/12) Normal Normal 
7 Aneuploidy (1/10) 
Polyploidy / 
Aneuploidy (9/11) 
Polyploidy / 
Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
8 Normal Polyploidy (9/11) Polyploidy / Aneuploidy (10/12) 
Polyploidy 
(10/10) 
Polyploidy 
(10/10) 
9 Aneuploidy (1/10) 
Polyploidy / 
Aneuploidy (9/11) Normal Normal Normal 
10 Polyploidy (1/10) Normal 
Polyploidy / 
Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
11 Normal Normal Polyploidy / Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
12 Normal Polyploidy / Aneuploidy (9/11) 
Polyploidy / 
Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
13 Normal Normal Polyploidy / Aneuploidy (10/12) 
Polyploidy 
(10/10) 
Polyploidy / 
Aneuploidy 
(10/10) 
14 Normal Polyploidy / Aneuploidy (9/11) Normal Normal 
Polyploidy 
(10/10) 
15 Normal Polyploidy / Aneuploidy (9/11) Normal Normal 
Polyploidy 
(10/10) 
16 Normal Normal Polyploidy (10/12) Polyploidy (10/10) 
Polyploidy 
(10/10) 
17 Polyploidy (1/10) Normal 
Polyploidy / 
Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
18 Normal Polyploidy / Aneuploidy (9/11) Normal Normal Normal 
19 Normal Normal Normal Normal 
Polyploidy / 
Aneuploidy 
(10/10) 
20 Normal Polyploidy / Aneuploidy (9/11) 
Polyploidy / 
Aneuploidy (10/12) 
Polyploidy 
(10/10) 
Polyploidy / 
Aneuploidy 
(10/10) 
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 Note: NK, normal kidney epithelia; PKD, polycystic kidney epithelia; PC3, prostate cancer epithelia;  
DU145, prostate cancer epithelia; NL, cancer lung epithelia 
 
 
 
Figure 0.4  Evaluation of primary cilia expression and length in epithelial cells. 
 
 
 
21 Aneuploidy (1/10) Normal 
Polyploidy / 
Aneuploidy (10/12) Normal 
Polyploidy 
(10/10) 
22 Normal Normal Polyploidy / Aneuploidy (10/12) 
Polyploidy 
(10/10) 
Polyploidy / 
Aneuploidy 
(10/10) 
X Normal Normal Normal Normal Normal 
Y Normal  Normal Normal  
 (A) Representative images of primary cilia in human epithelial cells. Primary cilia 
were identified by immunofluorescence using antibody against acetylated a-tubulin 
(green); actin filaments using texas red-conjugated phalloidin (red); and nuclei using 
DAPI (blue). (B) The percent of cells with cilia and the average cilia length of each 
cell type. (C) Histograms depict the distribution of cilia lengths in each cell type.  
Values are represented as mean±SEM. ****, p<0.0001 compared with the control 
(NK) cells.  N=4 independent experiments. 
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Rapamycin Partially Restored Primary Cilium Expression in Cancer Cells. 
Because primary cilium regulates cell cycle progression and can stop abnormal cell growth by 
restricting cell cycle [16, 22], restoration of the primary cilium in cancer cells may reduce cell 
proliferation.  Rapamycin has been previously shown to increase cilia formation and length [31, 
32].  Therefore, we treated the cells with different concentrations of rapamycin at different time 
points (1, 3, and 8 days).  Rapamycin did not induce ciliogenesis on day-1 and day-3 (data not 
shown), while 1 µM and 10 µM of rapamycin treatment on day-8 appeared to restore cilia 
formation in PC3, DU145, and NL (Fig. 2.7A).  Treatment of the cells with 1 µM and 10 µM of 
rapamycin significantly increased the expression of primary cilia in PC3, DU145, and NL 
compared to the control cells (Fig. 2.7B).  The cilia length was significantly increased with 1 or 
10 µM of rapamycin treatment compared to the control cells in NK, PKD, DU145, and NL but not 
in PC3.  Cilia lengths of each cell type were tabulated (Fig. 2.7C). 
 
Rapamycin Treatment Inhibited Cell Proliferation. 
Treatment with 10 µM of rapamycin caused a significant increase in primary cilia expression in 
the cancer epithelial cells.  A concentration of 10 μM was therefore selected for the rest of our 
experiments.  Before and after the cells were treated with 10 µM of rapamycin for 1, 3, and 8 days, 
cell proliferation (defined as the percentage of cells with an increase DNA synthesis) was assessed 
and analyzed by flow cytometry (Fig. 2.8).  In all cell lines, rapamycin treatment at different time 
points significantly increased the percentages of the cells in G1 phase (Fig. 2.8A).  Conversely, the 
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percentages of the cells in G2/M phase were significantly decreased by rapamycin treatment (Fig. 
2.8B).  We also validated the cell proliferation data using an independent BrdU staining method 
by determining the incorporation of the thymine analogs into newly synthesized DNA (Fig. 2.9).  
We found that rapamycin treatment for 8 days significantly reduced the percentage of BrdU-
positive cells compared to untreated control cells (Fig. 2.10). 
 
 
Figure 3.5  PKD and Cancer Epithelia were Highly Proliferative. 
 
 
 (A) The growth rates of the five cell types over a period of five days were examined by counting 
the cell number in each of the five days. (B) Quantitation of cell cycle phases in selected cells 
using propidium iodide.  The relative percentages of cells in G1 and G2/M under confluent condition 
or non-confluent condition are shown on this graph. Values are represented as mean±SEM. *, 
p<0.05; **, p<0.01; ***, p<0.001; and ****, p<0.0001 compared with the control NK.  N=3 for 
cell growth; N=8 for cell cycle analysis. 
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Figure 3.6  Quantitation of G1 and G2/M phases.   
 
 
Representative graphs show the percentages of cells with varying 
intensity of PI (propidium iodide) staining of NK, PKD, PC3, 
DU145, and NL under confluent and non-confluent conditions. 
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Effects of Rapamycin Treatment on Cell Proliferation, Cilia Expression, and Cilia Length. 
Pearson's correlation coefficient was used to measure the strength of the association between 
control and rapamycin treatment on the changes in cell proliferation, cilia expression or cilia length 
(Fig. 2.11).  The summary graphs before and after rapamycin treatment (Fig. 2.11A) were analyzed 
and derived using Pearson's correlation, in which linear regression graphs were used to show the 
strength of the correlation (Fig. 2.11B).  The rapamycin treatment was inversely correlated with 
the percent of cells in G2/M phase (r=0.730, p=0.162) but was positively correlated with the 
percent of cells with cilia (r=0.986, p=0.002) and cilia length (r=0.869, p=0.056).   
We subsequently analyzed the associations among cell proliferation, cilia expression and cilia 
length (Fig. 2.12).  The summary graphs between each association (Fig. 2.12A) were analyzed and 
derived using Pearson's correlation, in which linear regression graphs were used to show the 
strength of the correlation (Fig. 2.12B).  The percent of cells with cilia was inversely correlated 
with the percent of cells in G2/M phase (r=0.843, p=0.028).  Cilia length was also inversely 
correlated with the percent of cells in G2/M phase (r=0.964, p=0.003).  As expected, cilia length 
was positively correlated with the percent of cells with cilia (r=0.515, p=0.172).  These results 
indicated that rapamycin treatment was associated with increased cilia expression/length and 
decreased cell proliferation. 
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Figure 3.7  The effect of rapamycin treatment on ciliogenesis. 
 
 
 
 
 (A) The representative images that show primary cilia expression after treatment with 0, 1 or 10 µM of rapamycin for 8 
days in NK, PKD, PC3, DU145, and NL.  Primary cilia were identified by immunofluorescence using antibody against 
acetylated a-tubulin (green); actin filaments using texas red-conjugated phalloidin (red); and nuclei using DAPI (blue).  
(B) The percentages of cells with cilia and the average cilia length after treatment with 0, 1, or 10 µM of rapamycin for 8 
days in NK, PKD, PC3, DU145, and NL. (C) Histograms show the distribution of cilia length after rapamycin treatment 
(0, 1, or 10 µM).  Values are represented as mean±SEM. *, p< .05; **, p<0.01; ***, p<0.001; and ****, p<0.0001compared 
to control baseline of corresponding group . #, p<0.05; ##, p<0.01; ###, p<0.001; and ####, p<0.0001compared to normal 
kidney (NK) epithelia.  N=3 independent experiments with a total of at least 150 cilia measurements.  (NOTE: technically 
the ANOVA test results should be reported first, i.e., their p values. Only if their p values are significant, then the post-
test analysis need to be performed. As of now, the ANOVA p values are not reported.) 
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Figure 3.8  Inhibition of cell proliferation by rapamycin using propodium iodide.   
 
 
 
Rapamycin Treatment in Wnt/β-catenin Signaling Pathway. 
The level of hedgehog as well as Wnt/β-catenin signaling molecules were compared among 
different cell types using Western blot analyses (data not shown).  The expression levels of β-
catenin, the hallmark indicator of the canonical Wnt signaling pathway, were higher in PKD, PC3, 
DU145, and NL compared to NK.  However, there seemed to be no difference in the expression 
levels of Gli1 and smoothened (smo) among the different cell types. 
 
Quantitation of cell cycle phases using propidium iodide.  The relative percentages of 
cells in (A) G1 and (B) G2/M before and after treatment with 10 µM of rapamycin for 1, 
3, and 8 days in NK, PKD, PC3, DU145, and NL.  Values are represented as mean±SEM. 
*, p<0.05; **, p<0.01; ***, p<0.001; and ****, p<0.0001compared to control baseline 
of corresponding group. #, p<0.05; ##, p<0.01; ###, p<0.001; and ####, 
p<0.0001compared to control NK.  N=3 independent experiments.  
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Figure 3.9  Analysis of BrdU incorporation.   
 
Representative graphs show the numbers of cells (count) 
with varying incorporation (intensity) of BrdU staining in 
NK, PKD, PC3, DU145, and NL before and after treatment 
with 10 µM rapamycin for 8 days. 
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Figure 3.10  Inhibition of cell proliferation by rapamycin using BrdU.   
 
 
 
We subsequently evaluated the effects of 10 µM of rapamycin treatment for 1, 3, and 8 days on β-
catenin expression level (Fig. 2.13A).  On day 1 and 3 of rapamycin treatment, the expression 
level of b-catenin significantly increased in NK, PKD, and DU145 compared to their untreated 
cells.  The expression level of b-catenin significantly decreased in NK, PKD, and PC3 compared 
to their untreated cells on day 8.  Because rapamycin is a potent inhibitor of mTOR (mammalian 
target of rapamycin), the effects of rapamycin on the phosphorylation of mTOR at Ser2448 and its 
downstream target p70 S6-Kinase (S6K) were measured using Western blot. The phosphorylation 
of mTOR at Ser2448 was significantly reduced on day 1, 3, and 8 after rapamycin treatment 
The relative percentages of cells with BrdU before and after treatment with 
10 µM rapamycin for 8 days in NK, PKD, PC3, DU145, and NL.  Values are 
represented as mean±SEM. *, p<0.05; **, p<0.01; ***, p<0.001; and ****, 
p<0.0001compared to control baseline of corresponding group. #, p<0.05; ##, 
p<0.01; ###, p<0.001; and ####, p<0.0001compared to control NK.  N=3 
independent experiments.  
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Figure 3.11  One-Dimensional Correlation Analysis.  
 
 
compared to the corresponding non-treated NK, PKD, PC3 and DU145.  In NL, rapamycin did not 
change the phosphorylation of mTOR at Ser2448 on day 1 and 3; however, on day 8 rapamycin 
significantly increased mTOR phosphorylation.  The phosphorylation of S6K was significantly 
reduced at the following days: 8 days after rapamycin treatment in NK; 1, 3, and 8 days after 
rapamycin treatment in PKD and PC3 cells; 1 and 3 days after rapamycin treatment in DU145 
cells; and 3 days after rapamycin treatment in NL.  On the other hand, the phosphorylation of S6K 
(A) Pearson correlation was used to evaluate the association before and after rapamycin treatment on 
the changes in the percentage of cells in G2/M phase, percentage of cells with cilia, and cilia length.  
The p-value (p) represents the significance of the correlation coefficient.  (B) The results of Pearson 
linear regression analysis are shown in scattered plots.  The scattered plots show changes in each 
variable before and after rapamycin treatment.  Pearson correlation coefficient (r) shows the regression 
line and the upper and lower 95% confidence limits. 
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Figure 3.12  Two-Dimension Correlation analysis data 
 
 
 
was significantly elevated on day 8 of rapamycin treatment compared to untreated NL.  Because 
rapamycin did not inhibit the phosphorylation of mTOR at Ser2448 in NL, the effect of rapamycin 
on the phosphorylation of mTOR at another major site (Ser2481) was examined (Fig. 2.13B).  The 
(A) Pearson correlation was used to evaluate the correlations of the changes in cilia expression vs. cell 
proliferation, cilia length vs. cell proliferation, and cilia expression vs. cilia length.  The p-value (p) 
represents the significance of the correlation coefficient.  (B) The results of Pearson linear regression 
analysis are shown in scattered plots. The scattered plots show changes in two variables before and after 
rapamycin treatment.  Pearson correlation coefficient (r) shows the regression line and the upper and 
lower 95% confidence limits. 
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phosphorylation of mTOR Ser2481was significantly reduced on day 1, 3, and 8 after rapamycin 
treatment compared to the expression in the absence of rapamycin in NL.  
Immunofluorescence analysis was performed to determine the translocation of β-catenin into the 
nucleus (Fig. 2.13C).  In NK and PKD, 10 µM rapamycin treatment for 1 day significantly 
increased the translocation of b-catenin into the nucleus while treatment for 8 days significantly 
decreased the b-catenin nuclear translocation compared to untreated control.  In PC3 and DU145, 
treating the cells with rapamycin for 3 days significantly increased the b-catenin nuclear 
translocation and significantly decreased nuclear b-catenin after 8 days of treatment.  The nuclear 
b-catenin was significantly reduced by rapamycin treatment in NL. 
Original Western blot images prior to cropping are presented to show the effects of rapamycin on 
b-catenin, S6K, mTOR phosphorylation at S2448 (Fig. 2.14A) and S2481 (Fig. 2.14B).  
Representative images are also shown to determine cytosolic and nuclear b-catenin (Fig. 2.15). 
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Figure 3.13  Effects of Rapamycin on Signaling Molecules.   
 
 
 
 (A) The protein expressions of b-catenin, p-mTOR (Ser2448), p-S6k, and b -actin were analyzed before and 
after treatment with 10 µM of rapamycin for 1, 3, and 8 days in NK, PKD, PC3, DU145, and NL. (B) The 
protein expressions of p-mTOR (Ser2481) was separately analyzed in NL.  Relative expression levels are 
expressed as the density ratio relative to β-actin.  (C) Quantifications of nuclear and cytosolic accumulation of 
b-catenin were measured before and after treatment with 10 µM of rapamycin for 1, 3, and 8 days in NK, PKD, 
PC3, DU145, and NL. Values are represented as mean±SEM.  *, p<0.05; **, p<0.01; ***, p<0.001; and ****, 
p<0.0001compared to control baseline of corresponding group. #, p<0.05; ##, p<0.01; ###, p<0.001; and ####, 
p<0.0001compared to control NK.  N=3 independent experiments.  
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Figure 3.14  Representative Western blot images. 
 
 
 (A) Original, uncropped immunoblots of b-catenin, p-mTOR 
(Ser2448), p-S6k, and b-actin are shown before and after treatment 
with 10 µM of rapamycin for 1, 3, and 8 days in NK, PKD, PC3, 
DU145, and NL.  (B) Original blots of p-mTOR (Ser2481) and b-
actin are shown before and after treatment with 10 µM of rapamycin 
for 1, 3, and 8 days in NL.  The molecular weight (MWs) of the 
proteins are shown on the left of each corresponding blot. 
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Figure 3.15  Representative immunofluorescent images of β-catenin.  
β-catenin translocation was assessed before and after treatment with 10 µM         
of rapamycin for 1, 3, and 8 days in NK, PKD, PC3, DU145, and NL.  
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3.5. Discussion  
Based on the emerging concept that cancer is associated with loss of primary cilia [7, 9, 23, 24], 
we postulate that restoration of primary cilia formation may attenuate cancer proliferation.  In 
order to restore ciliogenesis in cancer cells, we treated the cells with rapamycin because rapamycin 
has been previously shown to increase cilia formation and length [31, 32]. We indeed found that 
rapamycin restored cilia formation and attenuated cell proliferation.  Furthermore, our analyses 
suggest that ciliogenesis and antiproliferative effects by rapamycin treatment are highly correlated 
with one another.   
Dysfunction of primary cilia has been associated with genomic instability [33, 47-49].  Cancer 
cells are also known to have genomic instability [50, 51]. Thus, we speculate that primary cilia 
may be involved in cancer pathogenesis.  Abnormal ploidy formation was indeed observed in PKD 
and cancer cells. Moreover, we found that dysfunction or loss of primary cilia is associated with 
increased proliferation rate.   
DU145 prostate cancer and NL bronchial tumorigenic cells did not express primary cilia while 
PC3 prostate cancer cells expressed low level of primary cilia.  Our results are consistent with the 
previous studies that show the absence of primary cilia in PC3 and DU145 prostate cancer [52].  
Our studies also agree with the previous report showing that prostate cancer tissues have a 
reduction in the percentage of ciliated cells [53].  After excluding cilia length of 1  m or less, we 
did not find any significant difference in cilia length among PC3, PKD, and NK.  In contrast, a 
previous study show that there are more primary cilia in lung adenocarcinoma as well as in other 
cancers, such as adenocarcinoma of the colon, follicular lymphoma, and pancreatic 
adenocarcinoma [54].  Another study shows that ciliogenesis has a role in promoting cancer drug 
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resistance [25].  Even in the same cancer type, primary cilia can have an opposing role in 
tumorigenesis depending on the oncogenic initiating event [14, 55], suggesting the complexity of 
the roles of cilia in cancer. 
We found that PKD, PC3, DU145, and NL are more proliferative than NK.  We observed that even 
after becoming confluent, a condition of growth arrest, PC3 and DU145 cells are still significantly 
more proliferative than NK cells.  The main physiological difference between immortalized cells 
and cancer cells is the loss of cell-cell contact inhibition in cancer cells (Fig. 4B).  Cancer cells 
continue to proliferate even after they have become confluent.  E-cadherin adhesive junctions are 
thought to play an important role in mediating contact inhibition through homophilic interactions 
of E-cadherin molecules between the two neighboring cells [56-58]. Previous studies have shown 
that over-expression of cadherins can antagonize β-catenin signaling by binding and sequestering 
it from the nuclear signaling [59, 60]. In cancer cells, loss of E-cadherin expression can contribute 
to upregulation of β-catenin signaling pathway [61]. It has been reported that overexpression of β-
catenin in epithelial cells promotes cell proliferation [62]. Compared to immortalized non-
tumorigenic cells, the genes involved in cell proliferation and cell cycle are significantly 
deregulated in tumorigenic cells [63]. Cyclin inhibitors and negative regulators of cell proliferation 
are progressively downregulated during tumorigenesis. 
The mammalian target of rapamycin (mTOR) signaling pathway is an essential regulator of cell 
proliferation and metabolism processes, which are directly controlled by the mTORC1 pathway, 
such as protein, lipid and nucleotide synthesis, energy metabolism, and autophagy.  Dysregulation 
of the mTOR pathway is involved in several diseases including cancer, diabetes, obesity, 
neurological diseases, and genetic disorders [64, 65].  Activation of mTORC1 stimulates 
glycolysis and lipid biosynthesis [66] and positively regulates glutamine metabolism [67].  
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Recently it is found that mTORC1 is also has an important role in aging and age-related diseases 
[68].  Rapamycin is a selective inhibitor of mTORC1and a potent inhibitor of S6K1 activation (the 
downstream target of mTOR) [69].  It is found that rapamycin treatment improves insulin 
sensitivity by preventing a S6K-mediated feedback loop [70]. Moreover, rapamycin treatment 
prevents the differentiation of human adipocyte [71] and protects against high-fat-diet-induced 
obesity [72].  Rapamycin also has a role in extending the lifespan and preventing the onset of many 
age-related diseases [73, 74].  This information signifies a broad spectrum of rapamycin in cellular 
signaling and cell processes.  Within the context of our work on cilia and cell proliferation, our 
studies do not differentiate cause-and-effect between cilia and cell proliferation.  We thus use 
rapamycin only as a pharmacological tool to examine the correlation between the changes in the 
cilia and cell proliferation. 
Rapamycin is an mTOR inhibitor and one of the most potent inducers of cilia formation.  
Rapamycin shows a statistically significant increase (up to 6-fold) in the percentage of cells with 
cilia compared to vehicle-treated cells [32].  Moreover, it has been shown that rapamycin increases 
primary cilia length and function in renal epithelia and vascular endothelia [31].  Consistent with 
these previous studies, our work demonstrates that rapamycin treatment for 8 days partially 
restores primary cilium expression in DU145 and NL cancer cells and significantly increases cilia 
length in NK, PKD, DU145, and NL.  We found that 10 µM of rapamycin increased the cilia length 
more than 1 µM of rapamycin treatment.  Cell cycle before and after 1, 3, and 8 days of rapamycin 
treatment was evaluated to determine if restoration of primary cilia was associated with attenuation 
of cell proliferation.  Our results show that rapamycin inhibited cell proliferation significantly after 
1, 3, and 8 days of treatment compared to the untreated cells.  Our analyses also indicated that 
there was a significant correlation between the percent of cells with cilia and cell proliferation.  
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Consistent with our finding, Khan et al. have previously shown that rapamycin exerts its 
antiproliferative effect in cancer cells at least in part through its ability to restore primary cilium 
formation [32].  
In unstimulated cells, β-catenin protein exists very little in cytoplasmic or nuclear fractions due to 
rapid degradation of β-catenin in the cytoplasm by the destruction complex that composed of the 
adenomatous polyposis coli protein, GSK-3β, and Axin/Conductin.  However, in the presence of 
a Wnt signal, a Frizzled family receptor and the downstream component Dvl are activated.  Dvl in 
turn leads to the inactivation of GSK-3β, resulting in the accumulation of cytoplasmic β-catenin.  
High levels of β-catenin in the cytosol result in its translocation into the nucleus and activation of 
expression of Wnt-responsive genes.  The presence of primary cilium controls the levels of 
expression of Wnt target genes by regulating the degradation of Disheveled (Dvl) [30].  Wnt 
signaling activation was observed in many cancers and may contribute to the cancer progression 
[75-78].  
We showed a higher level of b-catenin expression, which suggests the utilization of canonical Wnt 
signaling pathway in PKD, PC3, DU145, and NL.  Similar to the previous studies [79-81], our 
data indicated that dysfunction or loss of primary cilia was associated with the activation of Wnt 
signaling pathways.  However, other studies show a low activation of Wnt signaling pathway in 
prostate cancer [53, 82].  Due to the concept that the presence of primary cilium controls the levels 
of expression of Wnt target genes [26, 29], we evaluated the effect of primary cilia restoration on 
Wnt/β-catenin signaling pathway by measuring the total protein expression of b-catenin as well as 
b-catenin nuclear translocation.  We found that on day 1 and 3 of rapamycin treatment, the 
expression level of b-catenin was significantly increased in NK, PKD, and DU145 compared to 
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the untreated cells and the nuclear translocation of b-catenin increased significantly in NK, PKD, 
PC3 and DU145 compared to the untreated cells.  This effect is consistent with the previous study 
that shows that mTORC1 activation suppressed Wnt/β-catenin signaling and that rapamycin could 
activate Wnt/β-catenin signaling pathway [83, 84].  However, the expression level of b-catenin 
significantly decreased in NK, PKD, and PC3 compared to untreated cells after 8 days of 
rapamycin treatment.  Likewise, the b-catenin nuclear translocation significantly decreased in NK, 
PKD, PC3, and DU145 compared to untreated cells after 8 days of rapamycin treatment.  This 
reduction in b-catenin level is presumably due to the presence or increase length of primary cilia.  
Generally, there is a trend of an initial increase followed by a decrease of b-catenin level as well 
as the translocation of b-catenin into the nucleus with rapamycin treatment.  Moreover, we confirm 
the effect of rapamycin on inhibiting the phosphorylation of mTOR and its downstream target p70 
S6 Kinase (S6K).  In NL, rapamycin neither changes the level of b-catenin expression nor reduces 
the phosphorylation of both mTOR at Ser2448 and S6K. However, rapamycin significantly 
inhibits the phosphorylation of mTOR at Ser2481in NL.  The inhibition of mTOR phosphorylation 
at a different site (Ser2481) may trigger the compensatory increase in the phosphorylation of 
mTOR at Ser2448 and S6K on day 8 treatment.  In addition to the different phosphorylation site 
of mTOR, the accumulation of b-catenin in the cytosol instead of nucleus in NL may be the reason 
that NL behaves differently from other cells. 
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3.6.    Conclusion 
In summary, we showed that rapamycin increased the expression and/or length of primary cilia.  
Both the presence and length of primary cilia were correlated significantly with cell proliferation.  
Our study supports the idea that the antiproliferative effects of rapamycin are correlated with 
ciliogenesis. 
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Conclusion  
Most of the non-hematological cells express sensory organelles on their surface called primary 
cilia. Primary cilia transmit extracellular clues into intracellular signals for molecular and cellular 
responses that regulate proliferation, differentiation, and migration. Defects in primary cilia could 
result in various life-threatening diseases including cardiovascular diseases and cancer.  
In this review, we explained the ciliary structure and functional ciliary proteins to understand how 
cilia dysfunction can be associated with vascular disorders such as   hypertension, aneurysm and 
atherosclerosis. We also demonstrate the possible connections between primary cilia and 
cardiovascular disorders. Future studies that involve pharmacological agents are needed in order 
to understand whether or not targeting sensory functions of primary cilia would improve 
cardiovascular outcomes. 
In our study, we evaluated the association between cilia formation or length and cell cycle or 
division. Using Spectral Karyotyping (SKY) technique, we showed that PKD and the 
cancer/tumorigenic epithelial cells were associated with abnormal ploidy.  We also showed that 
PKD and the cancer epithelia were highly proliferative.  Our findings indicate that the cancer 
epithelial cells had a reduction in the presence and/or length of primary cilia compared with the 
normal kidney (NK) cells.  After restoring the expression and length of primary cilia in these cells 
using rapamycin, the following analyses implied that both the presence and length of primary cilia 
were inversely correlated with cell proliferation.  Collectively, our data suggest that restoring the 
presence and/or length of primary cilia may serve as a novel approach to inhibit cancer cell 
proliferation. 
